Q3 2020 Amphastar Pharmaceuticals Inc Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Amphastar third quarter earnings call. (Operator Instructions) As a reminder, this conference call may be recorded.
All statements in this press release and in the conference call referenced above that are not historical are forward-looking statements, including, among other things: statements relating to the company's expectations regarding future financial performance, backlogs, sales and marketing of its products, market size and growth; the timing of FDA filings or approvals, including the DMFs of ANP; the timing of the product launches, acquisitions and other matters related to its pipeline of product candidates; its share buyback program and other future events, such as the impact of the COVID-19 pandemic and related responses of business and governments to the pandemic on our operations and personnel; and on commercial activity and demand across the business operations and results of operations.
These statements are not historical facts but rather are based on Amphastarâs historical performance and its current expectations,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |